MERLIN, M D (2003). «Archaeological Evidence for the Tradition of Psychoactive Plant Use in the Old World». Economic Botany. 57 (3). pp. 295–323. doi:10.1663/0013-0001(2003)057
QUIDING H, LUNDQVIST G, BORÉUS L O, BONDESSON U, OHRVIK J (1993). «Analgesic effect and plasma concentrations of codeine and morphine after two dose levels of codeine following oral surgery». Eur. J. Clin. Pharmacol. 44 (4). pp. 319–23. PMID8513842. doi:10.1007/BF00316466 !CS1 manut: Nomes múltiplos: lista de autores (link)
ANDERSON T L (1998). «Drug identity change processes, race, and gender. III. Macrolevel opportunity concepts». Substance use & misuse. 33 (14). pp. 2721–35. PMID9869440. doi:10.3109/10826089809059347
BERTOL E, FINESCHI V, KARCH S, MARI F, RIEZZO I (2004). «Nymphaea cults in ancient Egypt and the New World: a lesson in empirical pharmacology». Journal of the Royal Society of Medicine. 97 (2). pp. 84–5. PMID14749409. doi:10.1258/jrsm.97.2.84 !CS1 manut: Nomes múltiplos: lista de autores (link)
HAYRY M (2004). «Prescribing cannabis: freedom, autonomy, and values». Journal of Medical Ethics. 30 (4). pp. 333–6. PMID15289511. doi:10.1136/jme.2002.001347
El-SEEDI H R, De SMET P A, BECK O, POSSNERT G, BRUHN J G (2005). «Prehistoric peyote use: alkaloid analysis and radiocarbon dating of archaeological specimens of Lophophora from Texas». Journal of Ethnopharmacology. 101 (1-3). pp. 238–42. PMID15990261. doi:10.1016/j.jep.2005.04.022 !CS1 manut: Nomes múltiplos: lista de autores (link)
BECKER H S (1967). «History, culture and subjective experience: an exploration of the social bases of drug-induced experiences». Journal of health and social behavior. 8 (3). pp. 163–76. PMID6073200. doi:10.2307/2948371
ZHANG J, XU M (2001). «Toward a molecular understanding of psychostimulant actions using genetically engineered dopamine receptor knockout mice as model systems». J Addict Dis. 20 (3). pp. 7–18. PMID11681595. doi:10.1300/J069v20n04_02
HOPS H, TILDESLEY E, LICHTENSTEIN E, ARY D, SHERMAN L (1990). «Parent-adolescent problem-solving interactions and drug use». The American journal of drug and alcohol abuse. 16 (3-4). pp. 239–58. PMID2288323. doi:10.3109/00952999009001586 !CS1 manut: Nomes múltiplos: lista de autores (link)
McCOUN R, REUTER P (1997). «Interpreting Dutch cannabis policy: reasoning by analogy in the legalization debate». Science. 278 (5335). pp. 47–52. PMID9311925. doi:10.1126/science.278.5335.47
MANNINEN B A (2006). «Medicating the mind: a Kantian analysis of overprescribing psychoactive drugs». Journal of medical ethics. 32 (2). pp. 100–5. PMID16446415. doi:10.1136/jme.2005.013540
fda.gov
United States Food and Drug Administration. CDER Data Standards Manual. Acessado em 26 de abril de 2009.
LI, X. PEARCE, R A. (2000). «Effects of halothane on GABA(A) receptor kinetics: evidence for slowed agonist unbinding». J. Neurosci. 20 (3). pp. 899–907. PMID10648694 !CS1 manut: Nomes múltiplos: lista de autores (link)
HARRISON N. SIMMONDS M. (1985). «Quantitative studies on some antagonists of N-methyl D-aspartate in slices of rat cerebral cortex». Br J Pharmacol. 84 (2). pp. 381–91. PMID2858237
QUIDING H, LUNDQVIST G, BORÉUS L O, BONDESSON U, OHRVIK J (1993). «Analgesic effect and plasma concentrations of codeine and morphine after two dose levels of codeine following oral surgery». Eur. J. Clin. Pharmacol. 44 (4). pp. 319–23. PMID8513842. doi:10.1007/BF00316466 !CS1 manut: Nomes múltiplos: lista de autores (link)
SCHATZBERG, A F (2000). «New indications for antidepressants». Journal of Clinical Psychiatry. 61 (11). pp. 9–17. PMID10926050
ANDERSON T L (1998). «Drug identity change processes, race, and gender. III. Macrolevel opportunity concepts». Substance use & misuse. 33 (14). pp. 2721–35. PMID9869440. doi:10.3109/10826089809059347
BERTOL E, FINESCHI V, KARCH S, MARI F, RIEZZO I (2004). «Nymphaea cults in ancient Egypt and the New World: a lesson in empirical pharmacology». Journal of the Royal Society of Medicine. 97 (2). pp. 84–5. PMID14749409. doi:10.1258/jrsm.97.2.84 !CS1 manut: Nomes múltiplos: lista de autores (link)
HAYRY M (2004). «Prescribing cannabis: freedom, autonomy, and values». Journal of Medical Ethics. 30 (4). pp. 333–6. PMID15289511. doi:10.1136/jme.2002.001347
El-SEEDI H R, De SMET P A, BECK O, POSSNERT G, BRUHN J G (2005). «Prehistoric peyote use: alkaloid analysis and radiocarbon dating of archaeological specimens of Lophophora from Texas». Journal of Ethnopharmacology. 101 (1-3). pp. 238–42. PMID15990261. doi:10.1016/j.jep.2005.04.022 !CS1 manut: Nomes múltiplos: lista de autores (link)
VETULANI J (2001). «Drug addiction. Part I. Psychoactive substances in the past and presence». Polish journal of pharmacology. 53 (3). pp. 201–14. PMID11785921
BECKER H S (1967). «History, culture and subjective experience: an exploration of the social bases of drug-induced experiences». Journal of health and social behavior. 8 (3). pp. 163–76. PMID6073200. doi:10.2307/2948371
ZHANG J, XU M (2001). «Toward a molecular understanding of psychostimulant actions using genetically engineered dopamine receptor knockout mice as model systems». J Addict Dis. 20 (3). pp. 7–18. PMID11681595. doi:10.1300/J069v20n04_02
HOPS H, TILDESLEY E, LICHTENSTEIN E, ARY D, SHERMAN L (1990). «Parent-adolescent problem-solving interactions and drug use». The American journal of drug and alcohol abuse. 16 (3-4). pp. 239–58. PMID2288323. doi:10.3109/00952999009001586 !CS1 manut: Nomes múltiplos: lista de autores (link)
McCOUN R, REUTER P (1997). «Interpreting Dutch cannabis policy: reasoning by analogy in the legalization debate». Science. 278 (5335). pp. 47–52. PMID9311925. doi:10.1126/science.278.5335.47
MANNINEN B A (2006). «Medicating the mind: a Kantian analysis of overprescribing psychoactive drugs». Journal of medical ethics. 32 (2). pp. 100–5. PMID16446415. doi:10.1136/jme.2005.013540
nlm.nih.gov
Medline Plus. Anesthesia. Acesso em 25 de abril de 2009.